FFCP PHASE1:Hg19::chr11:60233507..60233518,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=not supported | |||
|DPIdataset=robust | |||
|EntrezGene=931 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=7315 | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=274bp_to_ENST00000532418_5end | |||
|coexpression_cluster_id=C995 | |||
|description=CAGE_peak_3_at_MS4A1_5end | |||
|id=chr11:60233507..60233518,+ | |||
|ontology_enrichment_celltype=CL:0000945!3.39e-77!24;CL:0000826!3.39e-77!24;CL:0000542!8.06e-36!53;CL:0000051!8.06e-36!53;CL:0000236!1.21e-33!14;CL:0000838!4.84e-33!52;CL:0002087!1.18e-17!119;CL:0000738!3.38e-14!140;CL:0002031!2.57e-12!124;CL:0000785!5.13e-11!2;CL:0000955!5.13e-11!2;CL:0000818!5.13e-11!2;CL:0000954!5.13e-11!2;CL:0000816!5.13e-11!2;CL:0000037!1.46e-10!172;CL:0000566!1.46e-10!172;CL:0000988!1.08e-09!182;CL:0002032!4.14e-09!165;CL:0000837!4.14e-09!165;CL:0000817!1.30e-07!3;CL:0000842!7.09e-07!3 | |||
|ontology_enrichment_celltype_v019=CL:0000945;4.45e-114;24!CL:0000236;5.76e-60;13!CL:0000542;4.34e-30;53!CL:0000946;3.98e-14;1!CL:0000786;3.98e-14;1!CL:0000785;1.10e-13;1!CL:0000819;1.10e-13;1!CL:0002087;2.49e-10;104 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,4.49e-114,24;CL:0000826,4.49e-114,24;CL:0000236,2.79e-70,14;CL:0000838,6.46e-52,52;CL:0000542,6.56e-51,53;CL:0000051,6.56e-51,53;CL:0000785,8.70e-26,2;CL:0000955,8.70e-26,2;CL:0000818,8.70e-26,2;CL:0000954,8.70e-26,2;CL:0000816,8.70e-26,2;CL:0002087,2.05e-22,115;CL:0002031,2.03e-21,120;CL:0000738,1.01e-18,136;CL:0000817,1.51e-17,3;CL:0002032,1.45e-15,161;CL:0000837,1.45e-15,161;CL:0000037,7.55e-15,168;CL:0000946,3.98e-14,1;CL:0000786,3.98e-14,1;CL:0000980,3.98e-14,1;CL:0000988,5.22e-14,177;CL:0000819,1.83e-13,1 | |||
|ontology_enrichment_development_v019=CL:0000051;4.34e-30;53!CL:0000954;5.24e-26;2!UBERON:0006965;1.75e-07;2 | |||
|ontology_enrichment_disease=DOID:0060058!1.16e-16!10 | |||
|ontology_enrichment_disease_v019=DOID:630;1.10e-13;1!DOID:0050177;1.10e-13;1!DOID:4960;1.10e-13;1!DOID:0060073;1.10e-13;1!DOID:0070004;1.10e-13;1!DOID:8675;1.10e-13;1!DOID:0050427;1.10e-13;1 | |||
|ontology_enrichment_disease_v019_2=DOID:630,9.73e-14,1;DOID:0050177,9.73e-14,1;DOID:0050427,9.73e-14,1;DOID:4960,1.25e-13,1;DOID:0070004,1.25e-13,1;DOID:0060073,1.83e-13,1;DOID:8675,1.83e-13,1 | |||
|ontology_enrichment_uberon=UBERON:0000178!2.96e-18!15;UBERON:0000179!2.96e-18!15;UBERON:0000463!2.96e-18!15;UBERON:0002106!2.71e-14!3;UBERON:0004854!2.71e-14!3;UBERON:0009034!2.71e-14!3;UBERON:0002095!2.71e-14!3;UBERON:0004782!2.71e-14!3;UBERON:0003281!2.71e-14!3;UBERON:0009664!2.71e-14!3;UBERON:0002296!2.71e-14!3;UBERON:0005602!2.71e-14!3;UBERON:0001179!2.71e-14!3;UBERON:0006293!2.71e-14!3;UBERON:0004177!1.73e-10!7;UBERON:0001829!1.89e-10!2 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.36881557818649,1.9704141467987,1.81034797021462,0,0,0,0,0,0,0.697204805222715,0.853015394924529,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.521482918420201,0,0,0,0,0,0,0,0,0,0,0,0,0,1.75996244461323,1.09227722252426,0,2.13365111283254,1.20118796110804,0,0,0.954053754535364,1.1384259382189,2.93618594685469,1.91136614062614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.431428401637234,0.106727557803444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.507447609232169,0,0.569647187174163,0.238231775457789,0.411362273086194,0.648473311192717,0,0.79312517629427,0,0,0,0.743212700502875,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.828851746593443,0,0,0.246169610922139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.094728735294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.423366660328922,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157204305099666,0.414239055347196,0,0,2.43585196761792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.20550485762571,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.548257766857182,0,0,0,0,0,0,0,0,2.41991373867136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.118920090777569,0,0,0,0.0771741581079447,0,0,0,0,0,0,0,0,0.657887425858975,0.128915775947154,0.499705779624645,0,0,0,0,0.917458566809082,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0620747142958579,0,0,0,0,0,0.336760265072938,0,0,0,0,0,0,0,0,0,0,1.20764276154616,1.28227396921293 | |||
|short_description=p3@MS4A1 | |||
}} |
Revision as of 07:54, 11 January 2014
Short description: | p3@MS4A1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | No |
Description: | CAGE_peak_3_at_MS4A1_5end |
Coexpression cluster: | C995_B_plasma_lymphoma_xeroderma_acute_Burkitt_b |
Association with transcript: | 274bp_to_ENST00000532418_5end |
EntrezGene: | MS4A1 |
HGNC: | 7315 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 4.49e-114 | 24 |
pro-B cell | 4.49e-114 | 24 |
B cell | 2.79e-70 | 14 |
lymphoid lineage restricted progenitor cell | 6.46e-52 | 52 |
lymphocyte | 6.56e-51 | 53 |
common lymphoid progenitor | 6.56e-51 | 53 |
mature B cell | 8.70e-26 | 2 |
pre-B-II cell | 8.70e-26 | 2 |
transitional stage B cell | 8.70e-26 | 2 |
small pre-B-II cell | 8.70e-26 | 2 |
immature B cell | 8.70e-26 | 2 |
nongranular leukocyte | 2.05e-22 | 115 |
hematopoietic lineage restricted progenitor cell | 2.03e-21 | 120 |
leukocyte | 1.01e-18 | 136 |
precursor B cell | 1.51e-17 | 3 |
hematopoietic oligopotent progenitor cell | 1.45e-15 | 161 |
hematopoietic multipotent progenitor cell | 1.45e-15 | 161 |
hematopoietic stem cell | 7.55e-15 | 168 |
antibody secreting cell | 3.98e-14 | 1 |
plasma cell | 3.98e-14 | 1 |
plasmablast | 3.98e-14 | 1 |
hematopoietic cell | 5.22e-14 | 177 |
B-1 B cell | 1.83e-13 | 1 |
Ontology term | p-value | n |
---|---|---|
genetic disease | 9.73e-14 | 1 |
monogenic disease | 9.73e-14 | 1 |
xeroderma pigmentosum | 9.73e-14 | 1 |
bone marrow cancer | 1.25e-13 | 1 |
myeloma | 1.25e-13 | 1 |
lymphatic system cancer | 1.83e-13 | 1 |
lymphosarcoma | 1.83e-13 | 1 |